Monte Rosa Therapeutics, Inc. (GLUE)
Biological Products, (No Diagnostic Substances)
Latest Price
$16.52
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
5.23
P/B Ratio
3.16
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 7.69M | $126.0M | 9.12% | -- | 2026-03-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.72M | $110.0M | 7.97% | +1.60M | 2026-03-31 |
| BlackRock, Inc. | 5.64M | $92.0M | 6.69% | +1.46M | 2026-03-31 |
| TCG Crossover Management, LLC | 4.62M | $76.0M | 5.48% | -- | 2026-03-31 |
| BVF INC/IL | 4.46M | $73.0M | 5.29% | +625.0K | 2026-03-31 |
| BAKER BROS. ADVISORS LP | 4.35M | $71.0M | 5.15% | -- | 2026-03-31 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4.23M | $69.0M | 5.01% | +866.8K | 2026-03-31 |
| Vestal Point Capital, LP | 3.60M | $59.0M | 4.27% | +2.83M | 2026-03-31 |
| STATE STREET CORP | 3.35M | $55.0M | 3.98% | +1.25M | 2026-03-31 |
| BRAIDWELL LP | 3.21M | $52.0M | 3.80% | +2.26M | 2026-03-31 |